Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients

Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients

Abstract Background Interleukin 36 (IL-36), as a gradually recognized cytokine, is involved in the occurrence and evolution of autoimmune diseases. Nevertheless, the relationship between myasthenia gravis (MG) and IL-36 is rarely reported. Methods We evaluated the serum levels of IL-36 (IL-36α, IL-3...

Full description

Bibliographic Details
Main Authors: Qiu-Xia Zhang, Yue Li, Shu-Min Jiang, Lin-Jie Zhang, Ming Yi, Jing Wang, Yuan Qi, Li Yang, Chun-Sheng Yang
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Neurology
Subjects:
Biomarkers
Interleukin 36
Myasthenia gravis
Human
Online Access:http://link.springer.com/article/10.1186/s12883-020-01885-z

Internet

http://link.springer.com/article/10.1186/s12883-020-01885-z

Similar Items